News
34m
MetDaan on MSNTransform your Art with these Easy Drawing HacksTransform your Art with these Easy Drawing Hacks!! China sees Trump's new law as 'one of the greatest acts of strategic ...
1h
Wide World of Sports on MSNNRLW Highlights: Raiders v Dragons - Round 1Canberra Raiders host the St George Illawarra Dragons in Round 1 of the 2025 NRLW Premiership at GIO Stadium, Canberra.
Ginger also understands what it means to be a visible figure in the body-diverse community. Should she win All Stars 10, ...
I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
20h
Pharmaceutical Technology on MSNBig pharma braces for revenue headwinds as patent expiries loomA company expected to fare well during this time is Eli Lilly, with revenue forecast to improve by 165% in 2030. This will largely be driven by the company’s glucagon like peptide-1 receptor agonist ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive ...
UBS remains bullish on Eli Lilly’s future thanks to surging demand for its obesity and diabetes treatments. UBS predicts Zepbound sales could exceed market expectations by roughly 15%. Meanwhile, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results